The Krka Group sales totalled €603.8 million in the first half of the year (up 1%), resulting in €70.1 million of net profit. Krka Company sales revenues amounted to €539.7 million, resulting in €56.2 million of net profit.
Krka Group sales by Region
Sales in Krka’s domestic market were up 6% to €41.2 million, which is 6.8% of Group sales. The highest relative as well as absolute sales growth, of 27%, or €16.3 million, was recorded in Region South-East Europe, where sales totalled €76.8 million, which represents 12.7% of Group sales. Krka’s largest sales region was Region East Europe, where sales totalled €175.5 million, which is 29.1% of Group sales. Sales in this Region were down 6% compared to the same period last year.
The second largest region in terms of sales was West Europe, where Krka generated €150.4 million of sales (down 8%), which represents 24.9% of Group sales. Despite sales volume up 14%, decreasing prices caused the value of sales to drop. Product sales in Region Central Europe represented 23.4% of Group sales. The volume of sales was up 6% and the value of sales up 3% to €141.4 million. Six-month product sales in Region Overseas Markets totalled €18.5 million (25% increase), which represents 3.1% of Group sales.
Krka Group sales by product and service group
The Krka Group sold €499.4 million worth of prescription pharmaceuticals, down 2% compared to the same period last year. The volume of sold prescription pharmaceuticals increased by 12%, and the value of sales was also up in regions South-East Europe (up 29%), Overseas Markets (up 23%), Central Europe (up 1%) and Slovenia (up 1%). Prescription pharmaceuticals represent 82.7% of Krka Group sales.
For non-prescription products, sales value was down 1% compared to the same period last year, to €50.3 million (8.3% of Group sales), however sales volume was up 4%. The sales of animal health products were up 44% to €37.3 million, which is 6.2% of Group sales. Health resort and tourist services totalled €15.4 million in sales revenues, up one tenth from the same period last year (2.6% of Group sales).
In the first half of 2016 Krka was granted marketing authorisations for three new products and it obtained 170 new marketing authorisations in different markets, with which they expanded marketing opportunities for products from different indication groups. In the first half of 2016 the Krka Group allocated €61.8 million to investments, of which the controlling company invested €30 million and subsidiaries €31.8 million.
More information in press release.